Adipose Tissue-Derived Extracellular Vesicles: A Promising Biomarker and Therapeutic Strategy for Metabolic Disorders

Figure 2

Classification of adipose tissue-derived EVs and their mediation of interorgan crosstalk in metabolic diseases. The composition of adipose tissue EVs can be altered in different physiological states to affect organs in pathological conditions such as obesity or diabetes, and several studies have focused on the role of adipose tissue EVs in obesity-associated insulin resistance. This figure was created by using BioRender (https://biorender.com/).